You are here: Home > Library > Academic References > Lignan - Hormone-associated Cancers
Breast Cancer sources...
Endometrial and Ovarian Cancer sources...
Prostate Cancer sources...

Breast Cancer

return to top

Horn-Ross PL, Hoggatt KJ, West DW, et al.
Recent diet and breast cancer risk: the California Teachers Study (USA).
Cancer Causes Control. 2002;13(5):407-415. (read abstract)

Keinan-Boker L, van Der Schouw YT, Grobbee DE, Peeters PH.
Dietary phytoestrogens and breast cancer risk.
Am J Clin Nutr. 2004;79(2):282-288. (read abstract)

Linseisen J, Piller R, Hermann S, Chang-Claude J.
Dietary phytoestrogen intake and premenopausal breast cancer risk in a German case-control study.

Int J Cancer. 2004;110(2):284-290. (read abstract)

McCann SE, Moysich KB, Freudenheim JL, Ambrosone CB, Shields PG.
The risk of breast cancer associated with dietary lignans differs by CYP17 genotype in women.

J Nutr. 2002;132(10):3036-3041. (read abstract)

Horn-Ross PL, John EM, Lee M, et al.
Phytoestrogen consumption and breast cancer risk in a multiethnic population: the Bay Area Breast Cancer Study.

Am J Epidemiol. 2001;154(5):434-441. (read abstract)

Ingram D, Sanders K, Kolybaba M, Lopez D.
Case-control study of phyto-oestrogens and breast cancer.

Lancet. 1997;350(9083):990-994. (read abstract)

Dai Q, Franke AA, Jin F, et al.
Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai.

Cancer Epidemiol Biomarkers Prev. 2002;11(9):815-821. (read abstract)

return to top

den Tonkelaar I, Keinan-Boker L, Veer PV, et al.
Urinary phytoestrogens and postmenopausal breast cancer risk.

Cancer Epidemiol Biomarkers Prev. 2001;10(3):223-228. (read abstract)

Hulten K, Winkvist A, Lenner P, Johansson R, Adlercreutz H, Hallmans G.
An incident case-referent study on plasma enterolactone and breast cancer risk.

Eur J Nutr. 2002;41(4):168-176. (read abstract)

Pietinen P, Stumpf K, Mannisto S, Kataja V, Uusitupa M, Adlercreutz H.
Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland.

Cancer Epidemiol Biomarkers Prev. 2001;10(4):339-344. (read abstract)

Zeleniuch-Jacquotte A, Adlercreutz H, Shore RE, et al.
Circulating enterolactone and risk of breast cancer: a prospective study in New York.

Br J Cancer. 2004;91(1):99-105. (read abstract)

Kilkkinen A, Virtamo J, Vartiainen E, et al.
Serum enterolactone concentration is not associated with breast cancer risk in a nested case-control study.

Int J Cancer. 2004;108(2):277-280. (read abstract)

Olsen A, Knudsen KE, Thomsen BL, et al.
Plasma enterolactone and breast cancer incidence by estrogen receptor status.

Cancer Epidemiol Biomarkers Prev. 2004;13(12):2084-2089. (read abstract)


return to top

Endometrial and Ovarian Cancer

Horn-Ross PL, John EM, Canchola AJ, Stewart SL, Lee MM.
Phytoestrogen intake and endometrial cancer risk.
J Natl Cancer Inst. 2003;95(15):1158-1164. (read abstract)


McCann SE, Freudenheim JL, Marshall JR, Graham S.
Risk of human ovarian cancer is related to dietary intake of selected nutrients, phytochemicals and food groups.
J Nutr. 2003;133(6):1937-1942. (read abstract)


return to top

Prostate Cancer

Kilkkinen A, Virtamo J, Virtanen MJ, Adlercreutz H, Albanes D, Pietinen P.
Serum enterolactone concentration is not associated with prostate cancer risk in a nested case-control study.
Cancer Epidemiol Biomarkers Prev. 2003;12(11 Pt 1):1209-1212. (read abstract)

Stattin P, Adlercreutz H, Tenkanen L, et al.
Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study.
Int J Cancer. 2002;99(1):124-129. (read abstract)

Strom SS, Yamamura Y, Duphorne CM, et al.
Phytoestrogen intake and prostate cancer: a case-control study using a new database.
Nutr Cancer. 1999;33(1):20-25.
(read abstract)


return to Academic References